Alectinib hydrochloride for the adjuvant treatment of patients with ALK positive non-small-cell lung cancer

13 November 2024 - NICE has published final evidence-based recommendations on the use of alectinib hydrochloride for the adjuvant treatment ...

Read more →

New heart medicine for 18,000 New Zealanders

12 November 2024 - PHARMAC has decided to fund the medicine empagliflozin for thousands of people with a type of ...

Read more →

November 2024 decisions

11 November 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

PHARMAC funds new medicine and removes renewal criteria for ADHD and narcolepsy treatments

11 November 2024 - PHARMAC will make two changes for people with attention deficit hyperactivity disorder (ADHD) and narcolepsy this ...

Read more →

World leading approach to protect babies from RSV

10 November 2024 - Australian mums and their newborn babies will have free access to the best and most comprehensive ...

Read more →

Pharmas allege Government communication breakdown in medicine deferral crisis

10 November 2024 - Labor has failed to plan for the consequences of delaying drug subsidies and left hundreds of ...

Read more →

Canada's Drug Agency recommends Winrevair (sotatercept) for reimbursement

8 November 2024 - Merck announced that Canada's Drug Agency has recommended Winrevair (sotatercept) for reimbursement in combination with standard ...

Read more →

Health officials warn of ‘practical limitations’ to medicine subsidies despite ‘triage’

8 November 2024 - Fears of on-going delays to critical new medicine subsidies have been stoked by a Health Department ...

Read more →

Additional PBAC meeting

6 November 2024 - The Albanese Government is ensuring patients get access to life changing medications and treatments as quickly ...

Read more →

Newly funded medicine to benefit 110 more people with thyroid, liver, and kidney cancer

8 November 2024 - PHARMAC has decided to fund lenvatinib from 1 December 2024 for people with some types of ...

Read more →

Government scrambles after medicines delay outrage

6 November 2024 - Health Minister Mark Butler has directed the PBAC to hold an unprecedented extra meeting, after the ...

Read more →

PHARMAC publishes agenda for the November 2024 PTAC meeting

 6 November 2024 - PHARMAC has published the agenda for the upcoming 14-15 November 2024 PTAC meeting. ...

Read more →

Avapritinib for the treatment of patients with advanced systemic mastocytosis

6 November 2024 - NICE has published evidence-based recommendations on the use of avapritinib (Ayvakyt) for the treatment of adults ...

Read more →

Medicine access debacle deepens with invoices for delayed services

5 November 2024 - Pharmaceutical companies whose medicines have been indefinitely delayed are being charged $200,000 per application despite no services ...

Read more →

Fenfluramine hydrochloride for the treatment of patients 2 years of age and older with seizures associated with Lennox–Gastaut syndrome

5 November 2024 - Following an appeal, NICE has published further draft guidance on the use of using fenfluramine hydrochloride ...

Read more →